Log in to save to my catalogue

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6627451

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

About this item

Full title

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2019-06, Vol.20 (12), p.3049

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

In recent decades, the incidence of neuroendocrine tumors (NETs) has steadily increased. Due to the slow-growing nature of these tumors and the lack of early symptoms, most cases are diagnosed at advanced stages, when curative treatment options are no longer available. Prognosis and survival of patients with NETs are determined by the location of t...

Alternative Titles

Full title

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6627451

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6627451

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms20123049

How to access this item